BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31556250)

  • 1. Barriers and facilitators of clinical trial enrollment in a network of community-based pediatric oncology clinics.
    Russo C; Stout L; House T; Santana VM
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28023. PubMed ID: 31556250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives.
    Siembida EJ; Loomans-Kropp HA; Tami-Maury I; Freyer DR; Sung L; Crosswell HE; Pollock BH; Roth ME
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34104866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shared barriers and facilitators to enrollment of adolescents and young adults on cancer clinical trials.
    Mittal N; Saha A; Avutu V; Monga V; Freyer DR; Roth M
    Sci Rep; 2022 Mar; 12(1):3875. PubMed ID: 35264642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT).
    Durant RW; Wenzel JA; Scarinci IC; Paterniti DA; Fouad MN; Hurd TC; Martin MY
    Cancer; 2014 Apr; 120 Suppl 7(0 7):1097-105. PubMed ID: 24643647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minority Enrollment to Clinical Trials: Road to Increased Access.
    Vose J
    Oncology (Williston Park); 2021 Mar; 35(3):107. PubMed ID: 33818053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to Pediatric Oncologist Enrollment of Adolescents and Young Adults on a Cross-Network National Clinical Trials Network Supportive Care Cancer Clinical Trial.
    Mittal N; Langevin AM; Kyono W; Dickens DS; Grimes A; Salsman JM; Pollock BH; Roth M
    J Adolesc Young Adult Oncol; 2022 Feb; 11(1):117-121. PubMed ID: 33983848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of barriers and facilitators to clinical trial enrollment among adolescents and young adults with cancer: Identifying opportunities for intervention.
    Siembida EJ; Loomans-Kropp HA; Trivedi N; O'Mara A; Sung L; Tami-Maury I; Freyer DR; Roth M
    Cancer; 2020 Mar; 126(5):949-957. PubMed ID: 31869454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities.
    Aristizabal P; Singer J; Cooper R; Wells KJ; Nodora J; Milburn M; Gahagan S; Schiff DE; Martinez ME
    Pediatr Blood Cancer; 2015 Aug; 62(8):1337-44. PubMed ID: 25755225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A surveillance system for monitoring, public reporting, and improving minority access to cancer clinical trials.
    Carpenter WR; Tyree S; Wu Y; Meyer AM; DiMartino L; Zullig L; Godley PA
    Clin Trials; 2012 Aug; 9(4):426-35. PubMed ID: 22761398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a cluster-randomized minority recruitment trial: RECRUIT.
    Tilley BC; Mainous AG; Smith DW; McKee MD; Amorrortu RP; Alvidrez J; Diaz V; Ford ME; Fernandez ME; Hauser RA; Singer C; Landa V; Trevino A; DeSantis SM; Zhang Y; Daniels E; Tabor D; Vernon SW
    Clin Trials; 2017 Jun; 14(3):286-298. PubMed ID: 28545336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming Barriers: Evidence-Based Strategies to Increase Enrollment of Underrepresented Populations in Cancer Therapeutic Clinical Trials-a Narrative Review.
    Vuong I; Wright J; Nolan MB; Eggen A; Bailey E; Strickland R; Traynor A; Downs T
    J Cancer Educ; 2020 Oct; 35(5):841-849. PubMed ID: 31713103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative study of Oncology Clinicians' Perceptions of Barriers to Offering Clinical Trials to Underserved Populations.
    Perez GK; Oberoi AR; Finkelstein-Fox L; Park ER; Nipp RD; Moy B
    Cancer Control; 2023; 30():10732748231187829. PubMed ID: 37724824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network: A New Model for Addressing Site-Level Factors Impacting Clinical Trial Enrollment.
    Roth M; Mittal N; Saha A; Freyer DR
    J Adolesc Young Adult Oncol; 2020 Aug; 9(4):522-527. PubMed ID: 32077782
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of implicit bias in pediatric cancer clinical trials and enrollment recommendations among pediatric oncology providers.
    Graetz DE; Madni A; Gossett J; Kang G; Sabin JA; Santana VM; Russo CL
    Cancer; 2021 Jan; 127(2):284-290. PubMed ID: 33119199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing Barriers and Facilitators to Adolescent and Young Adult Clinical Trial Enrollment Across High- and Low-Enrolling Community-Based Clinics.
    Siembida EJ; Loomans-Kropp HA; Tami-Maury I; Freyer DR; Sung L; Crosswell HE; Pollock BH; Roth ME
    Oncologist; 2022 May; 27(5):363-370. PubMed ID: 35522559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.
    Roth ME; Unger JM; O'Mara AM; Lewis MA; Budd T; Johnson RH; Pollock BH; Blanke C; Freyer DR
    Cancer Med; 2020 Mar; 9(6):2146-2152. PubMed ID: 32009305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies addressing barriers to clinical trial enrollment of underrepresented populations: a systematic review.
    Heller C; Balls-Berry JE; Nery JD; Erwin PJ; Littleton D; Kim M; Kuo WP
    Contemp Clin Trials; 2014 Nov; 39(2):169-82. PubMed ID: 25131812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer.
    Hamel LM; Penner LA; Albrecht TL; Heath E; Gwede CK; Eggly S
    Cancer Control; 2016 Oct; 23(4):327-337. PubMed ID: 27842322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Qualitative Study Exploring Barriers and Facilitators of Enrolling Underrepresented Populations in Clinical Trials and Biobanking.
    Davis TC; Arnold CL; Mills G; Miele L
    Front Cell Dev Biol; 2019; 7():74. PubMed ID: 31114788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute-Designated Community Oncology Research Programs.
    Dickens DS; Roth ME; Pollock BH; Langevin AM
    JCO Oncol Pract; 2020 Oct; 16(10):e1060-e1066. PubMed ID: 32396490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.